Beta Bionics (BBNX) Shareholder's Equity (2023 - 2026)

Beta Bionics (BBNX) Shareholder's Equity (2023 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shareholder's Equity (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn 52.06 Bn
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn 22.98 Bn
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn 49.20 Bn
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn 26.10 Bn
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn 10.33 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 13.34 Bn
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn 2.96 Bn
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn 10.67 Bn
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn 7.20 Bn
10 Beta Bionics 617.66 Mn 587.36 Mn 16.44 Mn 271.25 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 271.25 Mn
Dec 31, 2025 287.61 Mn
Sep 30, 2025 294.76 Mn
Jun 30, 2025 301.63 Mn
Mar 31, 2025 313.75 Mn
Dec 31, 2024 -245.36 Mn
Sep 30, 2024 -228.85 Mn
Jun 30, 2024 -221.21 Mn
Mar 31, 2024 -214.32 Mn
Dec 31, 2023 -203.11 Mn